HARMONY will be attending the joint meeting of the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT) in Barcelona (January 30 to February 1, 2020). This meeting is the second of its kind and will focus on the latest developments in the field of chimeric antigen-receptor T-cells (CAR T-cells). EHA is one of the 53 HARMONY Alliance Partners.
Representatives of the HARMONY Alliance will be attending; contact us if you would like to arrange a direct meeting.
The 2020 EHA-EBMT meeting will build on the expertise shared at the first joint meeting held in February 2019. Leading physicians will be sharing their experiences with CAR T-cell therapy in their respective fields and discussing the ongoing research efforts to advance this revolutionary treatment. Click here to visit the official EHA-EBMT conference website.
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Read about our ongoing and upcoming research projects.
Become involved with HARMONY today! Contact us to find out how you can participate in ongoing and future hematology research initiatives.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
